Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,944,148
+$2,717,098 QoQ
Shares Held
103,132
+70.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#221
of 1,348 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,397,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $56,332,097 across 7 Drug Manufacturers - General names. NVO ranks #5 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,000 | $15,238,200 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
100,000 | $12,634,000 | |
| 3 | LLY |
ELI LILLY & Co
|
9,100 | $10,914,813 | |
| 4 | AZN |
Astrazeneca PLC
|
34,800 | $6,598,776 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
103,132 | $4,944,148 | |
| 6 | BIIB |
Biogen Inc.
|
21,000 | $4,537,260 | |
| 7 | MRK |
Merck & Co., Inc.
|
11,400 | $1,464,900 |
All Filings in NVO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,397,000 | 50,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $4,944,148 | 103,132 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,227,050 | 60,600 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $6,431,250 | 175,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $3,675,000 | 100,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $4,079,100 | 80,171 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $57,748,800 | 1,135,000 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $24,970,500 | 450,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $5,521,600 | 80,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $23,908,192 | 344,300 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $10,752,500 | 125,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $8,752,535 | 101,750 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $15,913,700 | 185,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $1,594,942 | 13,395 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $7,703,829 | 64,700 | Call | Sole | 2024-11-14 | |
| 2023-12-31 | $17,586,500 | 170,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $2,273,500 | 25,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,215,366 | 100,200 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $4,854,900 | 30,000 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $4,774,200 | 30,000 | Put | Sole | 2023-05-15 | |
| 2022-06-30 | $66,858 | 600 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $1,675,400 | 20,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||